Wave Life Sciences, Inc. (WVE)
3.18
-0.17
(-5.07%)
USD |
NASDAQ |
Oct 23, 16:00
3.175
0.00 (0.00%)
After-Hours: 20:00
Wave Life Sciences Net Income (Quarterly) : -69.36M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -69.36M |
| March 31, 2026 | -26.09M |
| December 31, 2025 | -53.18M |
| September 30, 2025 | -53.85M |
| June 30, 2025 | -50.47M |
| March 31, 2025 | -46.88M |
| December 31, 2024 | 29.25M |
| September 30, 2024 | -61.78M |
| June 30, 2024 | -32.92M |
| March 31, 2024 | -31.56M |
| December 31, 2023 | -16.26M |
| September 30, 2023 | 6.995M |
| June 30, 2023 | -21.10M |
| March 31, 2023 | -27.40M |
| December 31, 2022 | -43.71M |
| September 30, 2022 | -39.00M |
| June 30, 2022 | -41.30M |
| March 31, 2022 | -37.81M |
| December 31, 2021 | -34.78M |
| September 30, 2021 | -6.23M |
| June 30, 2021 | -38.77M |
| March 31, 2021 | -42.46M |
| Date | Value |
|---|---|
| December 31, 2020 | -28.79M |
| September 30, 2020 | -33.10M |
| June 30, 2020 | -40.53M |
| March 31, 2020 | -47.49M |
| December 31, 2019 | -56.77M |
| September 30, 2019 | -50.73M |
| June 30, 2019 | -41.94M |
| March 31, 2019 | -44.20M |
| December 31, 2018 | -37.89M |
| September 30, 2018 | -37.63M |
| June 30, 2018 | -35.89M |
| March 31, 2018 | -35.24M |
| December 31, 2017 | -30.79M |
| September 30, 2017 | -25.49M |
| June 30, 2017 | -24.60M |
| March 31, 2017 | -21.10M |
| December 31, 2016 | -18.45M |
| September 30, 2016 | -17.54M |
| June 30, 2016 | -11.56M |
| March 31, 2016 | -7.847M |
| December 31, 2015 | -7.099M |
| September 30, 2015 | -4.936M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -8.603M |
| CorMedix, Inc. | 25.99M |
| Eloxx Pharmaceuticals, Inc. | -4.502M |
| Breakthrough Chemistry, Inc. | -1.083M |
| BioStem Technologies, Inc. | -8.971M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.272M |
| Total Expenses (Quarterly) | 71.63M |
| EPS Diluted (Quarterly) | -0.34 |
| Enterprise Value | 167.61M |
| Gross Profit Margin (Quarterly) | -4.27% |
| Profit Margin (Quarterly) | -3.05K% |
| Earnings Yield | -34.17% |
| Normalized Earnings Yield | -34.17 |